1. Home
  2. CELH vs RDY Comparison

CELH vs RDY Comparison

Compare CELH & RDY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CELH
  • RDY
  • Stock Information
  • Founded
  • CELH 2004
  • RDY 1984
  • Country
  • CELH United States
  • RDY India
  • Employees
  • CELH N/A
  • RDY N/A
  • Industry
  • CELH Beverages (Production/Distribution)
  • RDY Biotechnology: Pharmaceutical Preparations
  • Sector
  • CELH Consumer Staples
  • RDY Health Care
  • Exchange
  • CELH Nasdaq
  • RDY Nasdaq
  • Market Cap
  • CELH 15.3B
  • RDY 11.6B
  • IPO Year
  • CELH N/A
  • RDY N/A
  • Fundamental
  • Price
  • CELH $41.73
  • RDY $13.43
  • Analyst Decision
  • CELH Strong Buy
  • RDY Strong Buy
  • Analyst Count
  • CELH 18
  • RDY 2
  • Target Price
  • CELH $62.39
  • RDY $16.95
  • AVG Volume (30 Days)
  • CELH 6.5M
  • RDY 1.2M
  • Earning Date
  • CELH 11-06-2025
  • RDY 10-24-2025
  • Dividend Yield
  • CELH N/A
  • RDY 0.53%
  • EPS Growth
  • CELH N/A
  • RDY 9.95
  • EPS
  • CELH 0.13
  • RDY 0.79
  • Revenue
  • CELH $2,125,838,000.00
  • RDY $3,851,623,984.00
  • Revenue This Year
  • CELH $85.38
  • RDY $6.29
  • Revenue Next Year
  • CELH $31.08
  • RDY $2.61
  • P/E Ratio
  • CELH $326.14
  • RDY $17.14
  • Revenue Growth
  • CELH 55.07
  • RDY 14.10
  • 52 Week Low
  • CELH $21.10
  • RDY $12.26
  • 52 Week High
  • CELH $66.74
  • RDY $16.17
  • Technical
  • Relative Strength Index (RSI)
  • CELH 18.33
  • RDY 36.71
  • Support Level
  • CELH $56.96
  • RDY $13.37
  • Resistance Level
  • CELH $61.49
  • RDY $13.52
  • Average True Range (ATR)
  • CELH 2.70
  • RDY 0.25
  • MACD
  • CELH -2.24
  • RDY -0.09
  • Stochastic Oscillator
  • CELH 5.19
  • RDY 15.21

About CELH Celsius Holdings Inc.

Celsius Holdings plays in the energy drink subsegment of the global nonalcoholic beverage market, with 95% of revenue concentrated in North America. The firm now owns three energy drink brands: Celsius, Alani Nu, and Rockstar Energy. It dedicates its efforts to product innovation and marketing while outsourcing manufacturing and packaging to third-party co-packers and distribution to PepsiCo. The firm issued convertible preferred shares following PepsiCo's investments in 2022 and 2025, giving the latter an 11% stake in Celsius.

About RDY Dr. Reddy's Laboratories Ltd

Dr. Reddy's is one of the largest generic drug manufacturers in the world. It has a significant presence in North America, a region that makes up roughly half of its generics sales, and it services India (about 20% of its generics sales), Russia (10%), and certain European and Latin American countries. Beyond simple generics, Dr. Reddy's also has a solid portfolio of injectables which make up 25% of its North America sales. In branded generic markets like India, Dr. Reddy's has established a compelling presence with its strong brand name and earned a top five spot in key therapeutic areas including oncology and gastroenterology. Dr. Reddy's also has an active pharmaceutical ingredient business that manufactures over 150 APIs and sells in over 75 countries.

Share on Social Networks: